openPR Logo
Press release

Urticaria Treatment Market To Witness an Exponentiation between 2020 and 2030

11-26-2020 08:04 PM CET | Health & Medicine

Press release from: Persistence Market Research

Urticaria affects around 15-25% of people at some point in their lives. The symptoms of the condition include itching followed by hives on any area of the body or the occurrence of bumps. It may be triggered by some food allergens, drug allergens, insect bites, bacterial/viral infection or any physical stimuli such as pressure, cold, heat, exercise or sun exposure. Acute urticaria incidence is higher in people with atopy, and the condition mostly develops in children and young adults. Chronic urticaria occurs as episodic or daily hives lasting for at least six weeks, thus impairing the quality of life. According to World Allergy Organization, up to 1.8% of the population is currently suffering from chronic urticaria. The main objective of the urticaria treatment is to control the severity of these lesions and reduce pain and itching. Urticaria is caused by the release of certain vasoactive substances such as bradykinin, histamine, prostaglandin D2, and leukotriene C4 from mast cells & basophils in the dermis which results in causing extravasation of plasma into the dermis, thus developing an urticarial lesion. The peak incidence of the disease occurs in the age of 20-40 years. The condition is extremely distressing and affects patient’s quality of life.

Urticaria treatment starts with the physical examination and observing medical history followed by various histopathological tests. It includes restricting the use of certain allergens as well as taking antihistamines and other medications which block the symptom producing substance release. A combination approach is usually adopted to lower down the disease symptoms but the best option for urticaria treatment is to remove the trigger with the consultation of a specialist.

For detailed insights on enhancing your product footprint, request for a Sample Report here https://www.persistencemarketresearch.com/samples/23107

Urticaria Treatment market: Drivers & Restraints

There exist several factors supporting the growth of urticaria treatment market such as the availability of generic medications, easy availability via all distribution channels, rising awareness for hypersensitivity and increasing clinical access to diverse geographical areas. There are very few developments for the novel drug formulations in urticaria treatment which however limits the market. Along with this, preference towards other treatment options such as naturopathy, homeopathy etc. also restricts the market growth for urticaria treatment.

Urticaria Treatment market: Segmentation

By Disease Type:

Acute Urticaria
Chronic Urticaria
To receive extensive list of important regions, ask for TOC here https://www.persistencemarketresearch.com/toc/23107

By Drug Type:

Antihistamines
Histamine (H-2) Blockers
Anti-inflammation Medications
Antidepressants
Monoclonal Antibodies
Immune-Suppressing Drugs
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Drug Stores
Urticaria treatment mainly involves generic drugs such as anti-histamines or anti-inflammatory medications. There exists an opportunity for the market players to develop novel medications for the chronic urticaria treatment and thus replacing the conventional therapeutics for improving the quality of life such as the approval of Omalizumab in 2014 for chronic hives. Most of the clinical trial studies revolve around the chronic urticarial condition.

Geographically, the market for Urticaria Treatment can be segmented into five regions – North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America dominates the global Urticaria treatment market owing to the robust healthcare infrastructure, easy access to healthcare facilities as well as companies in these regions also focus on the development of novel formulations for chronic urticaria treatment. This is followed by the European market because of high awareness about the disease and people focusing on improving the quality of life. Asia-Pacific is expected to have a significant growth rate during the forecast period owing to the improving access to healthcare facilities as well as increasing healthcare expenditure in the region. Latin America followed by MEA is expected to have comparatively less market share for urticaria treatment during the forecast period but the growth rate is expected to increase with significant developments being done to improve the healthcare facilities in the region.

Some of the players in the Urticaria Treatment market includes Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Genentech USA, Inc., Novartis Pharmaceuticals Corporation, McNeil Consumer Pharmaceuticals Co., Pernix Therapeutics, Merck & Co., Inc. and others.

For in-depth competitive analysis, Check Pre-Book here https://www.persistencemarketresearch.com/checkout/23107

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urticaria Treatment Market To Witness an Exponentiation between 2020 and 2030 here

News-ID: 2196982 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Urticaria

Chronic Spontaneous Urticaria Market to Show a Rise During the Forecast Period, …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as well as the Chronic Spontaneous Urticaria market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Spontaneous Urticaria market report provides current treatment practices, emerging drugs, Chronic Spontaneous Urticaria market share of the individual therapies, and current
Urticaria Drug Market Analysis By Industry Size, Share, Revenue Growth and Deman …
The global urticaria drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Urticaria also known as hives, occurs when the body reacts to an allergen and releases histamine and other chemicals from under the surface of the skin. The major factor expected to drive the market is the rising incidences of urticaria, growing drug approvals for urticaria treatment, easy availability of generic medication, and growing
08-16-2021 | Health & Medicine
Fact.MR
Urticaria Pigmentosa Treatment Market Forecasting, Trend Analysis, Competitive T …
250 Pages Urticaria Pigmentosa Treatment Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider Subtitle –Fact MR Analysis of Urticaria Pigmentosa Treatment market provides compelling insights into the factors propelling sales prospects in key segments. It provides an executive-level blueprint of key market players' strategies and analyses their impact on overall growth projections According to Fact MR’s recent market research, Urticaria Pigmentosa Treatment sales will increase at propelled
Chronic Urticaria Or Hives - Pipeline Review, H2 2017 Published by MarketResearc …
“The Report Chronic Urticaria Or Hives - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz” Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Urticaria Or Hives - Pipeline Review, H2 2017, provides an overview of the Chronic Urticaria Or Hives (Dermatology) pipeline landscape. Chronic urticaria also known as hives, are an outbreak of swollen, pale red
Chronic Urticaria Or Hives - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Urticaria Or Hives - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Chronic Urticaria Or Hives. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265431 The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Chronic Urticaria
Global Analysis For Chronic Urticaria Or Hives Clinical Trials Review, H1, 2016
"The Report Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Summary GlobalData's clinical trial report, Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Urticaria Or Hives clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Urticaria Or Hives.